» Articles » PMID: 34049877

Molecular Mechanisms of Metabotropic GABA Receptor Function

Overview
Journal Sci Adv
Specialties Biology
Science
Date 2021 May 29
PMID 34049877
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Metabotropic γ-aminobutyric acid G protein-coupled receptors (GABA) represent one of the two main types of inhibitory neurotransmitter receptors in the brain. These receptors act both pre- and postsynaptically by modulating the transmission of neuronal signals and are involved in a range of neurological diseases, from alcohol addiction to epilepsy. A series of recent cryo-EM studies revealed critical details of the activation mechanism of GABA Structures are now available for the receptor bound to ligands with different modes of action, including antagonists, agonists, and positive allosteric modulators, and captured in different conformational states from the inactive to the fully active state bound to a G protein. These discoveries provide comprehensive insights into the activation of the GABA receptor, which not only broaden our understanding of its structure, pharmacology, and physiological effects but also will ultimately facilitate the discovery of new therapeutic drugs and neuromodulators.

Citing Articles

Enteric GABAergic neuron-derived γ-aminobutyric acid initiates expression of Igfbp7 to sustain ILC3 homeostasis.

Liu N, He J, Yang Y, Wang Y, Zhang L, Xiao Z Nat Immunol. 2025; 26(3):404-415.

PMID: 40033120 DOI: 10.1038/s41590-025-02081-2.


Insights and progress on the biosynthesis, metabolism, and physiological functions of gamma-aminobutyric acid (GABA): a review.

Zhang Q, Zhu L, Li H, Chen Q, Li N, Li J PeerJ. 2024; 12:e18712.

PMID: 39703920 PMC: 11657192. DOI: 10.7717/peerj.18712.


The pentameric chloride channel BEST1 is activated by extracellular GABA.

Pant S, Tam S, Long S bioRxiv. 2024; .

PMID: 39605608 PMC: 11601618. DOI: 10.1101/2024.11.22.624909.


Presynaptic hyperexcitability reversed by positive allosteric modulation of a GABABR epilepsy variant.

Minere M, Mortensen M, Dorovykh V, Warnes G, Nizetic D, Smart T Brain. 2024; 148(2):533-548.

PMID: 39028675 PMC: 11788220. DOI: 10.1093/brain/awae232.


Pathogenesis, diagnosis, and treatment of epilepsy: electromagnetic stimulation-mediated neuromodulation therapy and new technologies.

Jiao D, Xu L, Gu Z, Yan H, Shen D, Gu X Neural Regen Res. 2024; 20(4):917-935.

PMID: 38989927 PMC: 11438347. DOI: 10.4103/NRR.NRR-D-23-01444.


References
1.
Samocha K, Robinson E, Sanders S, Stevens C, Sabo A, McGrath L . A framework for the interpretation of de novo mutation in human disease. Nat Genet. 2014; 46(9):944-50. PMC: 4222185. DOI: 10.1038/ng.3050. View

2.
Froestl W, Gallagher M, Jenkins H, Madrid A, Melcher T, Teichman S . SGS742: the first GABA(B) receptor antagonist in clinical trials. Biochem Pharmacol. 2004; 68(8):1479-87. DOI: 10.1016/j.bcp.2004.07.030. View

3.
Ong J, Bexis S, Marino V, Parker D, KERR D, Froestl W . CGP 36216 is a selective antagonist at GABA(B) presynaptic receptors in rat brain. Eur J Pharmacol. 2001; 415(2-3):191-5. DOI: 10.1016/s0014-2999(01)00842-1. View

4.
Dore A, Okrasa K, Patel J, Serrano-Vega M, Bennett K, Cooke R . Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain. Nature. 2014; 511(7511):557-62. DOI: 10.1038/nature13396. View

5.
Deupi X, Kobilka B . Energy landscapes as a tool to integrate GPCR structure, dynamics, and function. Physiology (Bethesda). 2010; 25(5):293-303. PMC: 3056154. DOI: 10.1152/physiol.00002.2010. View